Expression Profiles of microRNAs in Drug-Resistant Non-Small Cell Lung Cancer Cell Lines Using microRNA Sequencing
Background/Aims: Drug resistance remains a main obstacle to the treatment of non- small cell lung cancer (NSCLC). The aim of this study was to identify the expression profiles of microRNAs (miRNAs) in drug-resistant NSCLC cell lines. Methods: The expression profiles of miRNAs in drug-resistant NSCLC...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Cell Physiol Biochem Press GmbH & Co KG
2018-12-01
|
Series: | Cellular Physiology and Biochemistry |
Subjects: | |
Online Access: | https://www.karger.com/Article/FullText/495921 |
_version_ | 1818174090280697856 |
---|---|
author | Shousen Hu Yongliang Yuan Zhizhen Song Dan Yan Xiangzhen Kong |
author_facet | Shousen Hu Yongliang Yuan Zhizhen Song Dan Yan Xiangzhen Kong |
author_sort | Shousen Hu |
collection | DOAJ |
description | Background/Aims: Drug resistance remains a main obstacle to the treatment of non- small cell lung cancer (NSCLC). The aim of this study was to identify the expression profiles of microRNAs (miRNAs) in drug-resistant NSCLC cell lines. Methods: The expression profiles of miRNAs in drug-resistant NSCLC cell lines were examined using miRNA sequencing, and the common dysregulated miRNAs in these cell lines were identified and analyzed by bioinformatics methods. Results: A total of 29 upregulated miRNAs and 36 downregulated miRNAs were found in the drug-resistant NSCLC cell lines, of which 26 upregulated and 36 downregulated miRNAs were found to be involved in the Ras signaling pathway. The expression levels, survival analysis, and receiver operating characteristic curve of the dysregulated miRNAs based on The Cancer Genome Atlas database for lung adenocarcinoma showed that hsa-mir-192, hsa-mir-1293, hsa-mir-194, hsa-mir-561, hsa-mir-205, hsa-mir-30a, and hsa-mir-30c were related to lung cancer, whereas only hsa-mir-1293 and hsa-mir-561 were not involved in drug resistance. Conclusion: The results of this study may provide novel biomarkers for drug resistance in NSCLC and potential therapies for overcoming drug resistance, and may also reveal the potential mechanisms underlying drug resistance in this disease. |
first_indexed | 2024-12-11T19:38:52Z |
format | Article |
id | doaj.art-b4838b29cf244cd586a88f0e0e5a24d6 |
institution | Directory Open Access Journal |
issn | 1015-8987 1421-9778 |
language | English |
last_indexed | 2024-12-11T19:38:52Z |
publishDate | 2018-12-01 |
publisher | Cell Physiol Biochem Press GmbH & Co KG |
record_format | Article |
series | Cellular Physiology and Biochemistry |
spelling | doaj.art-b4838b29cf244cd586a88f0e0e5a24d62022-12-22T00:53:05ZengCell Physiol Biochem Press GmbH & Co KGCellular Physiology and Biochemistry1015-89871421-97782018-12-015162509252210.1159/000495921495921Expression Profiles of microRNAs in Drug-Resistant Non-Small Cell Lung Cancer Cell Lines Using microRNA SequencingShousen HuYongliang YuanZhizhen SongDan YanXiangzhen KongBackground/Aims: Drug resistance remains a main obstacle to the treatment of non- small cell lung cancer (NSCLC). The aim of this study was to identify the expression profiles of microRNAs (miRNAs) in drug-resistant NSCLC cell lines. Methods: The expression profiles of miRNAs in drug-resistant NSCLC cell lines were examined using miRNA sequencing, and the common dysregulated miRNAs in these cell lines were identified and analyzed by bioinformatics methods. Results: A total of 29 upregulated miRNAs and 36 downregulated miRNAs were found in the drug-resistant NSCLC cell lines, of which 26 upregulated and 36 downregulated miRNAs were found to be involved in the Ras signaling pathway. The expression levels, survival analysis, and receiver operating characteristic curve of the dysregulated miRNAs based on The Cancer Genome Atlas database for lung adenocarcinoma showed that hsa-mir-192, hsa-mir-1293, hsa-mir-194, hsa-mir-561, hsa-mir-205, hsa-mir-30a, and hsa-mir-30c were related to lung cancer, whereas only hsa-mir-1293 and hsa-mir-561 were not involved in drug resistance. Conclusion: The results of this study may provide novel biomarkers for drug resistance in NSCLC and potential therapies for overcoming drug resistance, and may also reveal the potential mechanisms underlying drug resistance in this disease.https://www.karger.com/Article/FullText/495921miRNAsDrug resistanceNon-small cell lung cancerhsa-mir-561hsa-mir-1293 |
spellingShingle | Shousen Hu Yongliang Yuan Zhizhen Song Dan Yan Xiangzhen Kong Expression Profiles of microRNAs in Drug-Resistant Non-Small Cell Lung Cancer Cell Lines Using microRNA Sequencing Cellular Physiology and Biochemistry miRNAs Drug resistance Non-small cell lung cancer hsa-mir-561 hsa-mir-1293 |
title | Expression Profiles of microRNAs in Drug-Resistant Non-Small Cell Lung Cancer Cell Lines Using microRNA Sequencing |
title_full | Expression Profiles of microRNAs in Drug-Resistant Non-Small Cell Lung Cancer Cell Lines Using microRNA Sequencing |
title_fullStr | Expression Profiles of microRNAs in Drug-Resistant Non-Small Cell Lung Cancer Cell Lines Using microRNA Sequencing |
title_full_unstemmed | Expression Profiles of microRNAs in Drug-Resistant Non-Small Cell Lung Cancer Cell Lines Using microRNA Sequencing |
title_short | Expression Profiles of microRNAs in Drug-Resistant Non-Small Cell Lung Cancer Cell Lines Using microRNA Sequencing |
title_sort | expression profiles of micrornas in drug resistant non small cell lung cancer cell lines using microrna sequencing |
topic | miRNAs Drug resistance Non-small cell lung cancer hsa-mir-561 hsa-mir-1293 |
url | https://www.karger.com/Article/FullText/495921 |
work_keys_str_mv | AT shousenhu expressionprofilesofmicrornasindrugresistantnonsmallcelllungcancercelllinesusingmicrornasequencing AT yongliangyuan expressionprofilesofmicrornasindrugresistantnonsmallcelllungcancercelllinesusingmicrornasequencing AT zhizhensong expressionprofilesofmicrornasindrugresistantnonsmallcelllungcancercelllinesusingmicrornasequencing AT danyan expressionprofilesofmicrornasindrugresistantnonsmallcelllungcancercelllinesusingmicrornasequencing AT xiangzhenkong expressionprofilesofmicrornasindrugresistantnonsmallcelllungcancercelllinesusingmicrornasequencing |